Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells. [electronic resource]
Producer: 20140110Description: 648-56 p. digitalISSN:- 1582-4934
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Breast Neoplasms -- drug therapy
- Caspases -- metabolism
- Cell Death -- drug effects
- Cell Line, Tumor
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Female
- Furans -- pharmacology
- Gefitinib
- Humans
- Inhibitory Concentration 50
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Pyridines -- pharmacology
- Pyrimidines -- pharmacology
- Quinazolines -- pharmacology
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.